- Home
- ARCT vs PMI Comparison
ARCT vs PMI Comparison
Compare ARCT & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARCT | PMI |
|---|---|---|
| Founded | 2013 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.9M | 202.7M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARCT | PMI |
|---|---|---|
| Price | $6.87 | $1.06 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $27.70 | N/A |
| AVG Volume (30 Days) | ★ 460.5K | 181.0K |
| Earning Date | 03-03-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $82,031,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.85 | $0.96 |
| 52 Week High | $24.14 | $13.68 |
Technical Indicators
Market Signals| Indicator | ARCT | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 44.29 | 37.10 |
| Support Level | $5.93 | N/A |
| Resistance Level | $7.88 | $1.37 |
| Average True Range (ATR) | 0.39 | 0.12 |
| MACD | -0.08 | 0.02 |
| Stochastic Oscillator | 34.93 | 24.39 |
Price Performance
Historical ComparisonAbout ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
About PMI Picard Medical Inc.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.